Seeing Is Believing

Currently out of the existing stock ratings of John Walsh, 104 are a HOLD (35.37%), 170 are a BUY (57.82%), 20 are a SELL (6.8%).
Analyst John Walsh, carries an average stock price target met ratio of 67.72% that have a potential upside of 27.95% achieved within 330 days. Previously, John Walsh worked at CREDIT SUISSE.
John Walsh’s has documented 623 price targets and ratings displayed on 39 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare, Utilities sectors.
Most recent stock forecast was given on PNT, POINT Biopharma Global at 04-Oct-2023.
Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) at 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%) receiving and performance score of 62.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Oct-2025
$176
$33.51 (23.52%)
$180
26 days ago
(23-Feb-2026)
25/34 (73.53%)
$17.33 (10.92%)
272
Hold Since 22-Oct-2020
$190
$47.51 (33.34%)
$175
5 months ago
(21-Oct-2025)
18/19 (94.74%)
$11.09 (6.20%)
384
Buy Since 10-Sep-2021
$198
$55.51 (38.96%)
$170
6 months 5 days ago
(16-Sep-2025)
7/8 (87.5%)
$21.51 (12.19%)
548
Hold Since 23-Feb-2024
$170
$27.51 (19.31%)
$155
6 months 22 days ago
(27-Aug-2025)
14/14 (100%)
$-0.96 (-0.56%)
320
Hold Since 11-Jul-2022
$175
$32.51 (22.82%)
$110
7 months 20 days ago
(29-Jul-2025)
7/7 (100%)
$11.88 (7.28%)
492
What Year was the first public recommendation made by John Walsh?